Takeda Oncology Executive and Leadership Team

Marcelo Barretta, the Chief Financial Officer at Takeda Oncology, directs all financial operations and strategic fiscal planning. Barretta oversees budgeting, forecasting, and resource allocation, ensuring robust financial health for the oncology business unit. This leadership role involves managing investment strategies and optimizing financial performance to support the development and production of life-saving oncology therapies. Marcelo Barretta's expertise drives fiscal discipline and enables Takeda Oncology to pursue ambitious research and development initiatives. The Chief Financial Officer's purview extends to financial risk management and ensuring compliance with global financial regulations, thereby safeguarding the company's assets and long-term viability. Barretta's strategic financial guidance is critical for sustaining Takeda Oncology's global reach and impact in developing innovative cancer treatments.

Christophe Bianchi, the President at Takeda Oncology, spearheads the strategic direction and overall growth of the oncology business unit. Bianchi directs global operations, focusing on advancing the development and commercialization of Takeda Oncology's innovative therapeutic pipeline. This executive leadership role involves fostering strategic partnerships, driving market expansion, and ensuring the successful delivery of oncology treatments to patients worldwide. Christophe Bianchi's vision guides the organization's efforts to address critical unmet needs in cancer care. The President's responsibilities encompass overseeing research and development, regulatory affairs, and commercial strategies to maximize patient access and therapeutic impact. Bianchi's leadership is instrumental in solidifying Takeda Oncology's position as a leader in the fight against cancer, championing advancements in patient outcomes.

Teresa Bitetti, the Global President, Oncology Business Unit at Takeda Oncology, leads the strategic vision and execution for all global oncology operations. Bitetti drives the advancement and commercialization of Takeda Oncology's innovative therapies, focusing on patient access and therapeutic impact across diverse cancer types. This critical role involves orchestrating global teams to accelerate drug development, navigate complex regulatory landscapes, and ensure the effective delivery of treatments to patients worldwide. Teresa Bitetti's leadership is central to Takeda Oncology's mission of developing and producing life-changing oncology medicines. The Global President, Oncology Business Unit's purview includes fostering strategic collaborations and optimizing market strategies to address significant unmet medical needs in oncology. Bitetti's dedication ensures Takeda Oncology remains at the forefront of cancer research and patient care.

Rob Smith, the President at Takeda Oncology, directs the strategic initiatives and operational execution for the oncology business unit. Smith focuses on advancing the company's pipeline of innovative oncology therapies and expanding their global reach to patients in need. This leadership position involves overseeing key functions critical to drug development, market access, and commercial success. Rob Smith's strategic oversight ensures Takeda Oncology effectively addresses complex cancer challenges and delivers meaningful patient outcomes. The President's responsibilities include fostering a culture of innovation and collaboration among global teams, driving forward the development and production of groundbreaking cancer treatments. Smith's leadership is pivotal in reinforcing Takeda Oncology's commitment to transforming patient lives through advanced oncology solutions.

Tawnee Friedrich, the Chief Of Staff, GMAO at Takeda Oncology, provides strategic operational support and drives key initiatives across the Global Medical Affairs and Oncology (GMAO) organization. Friedrich coordinates cross-functional projects, enhances operational efficiency, and ensures alignment with Takeda Oncology's overarching mission to develop and deliver innovative cancer therapies. This role demands meticulous planning and execution to streamline processes and facilitate effective communication between various departments. Tawnee Friedrich's contributions are vital for optimizing the operational framework that supports global oncology research and patient access programs. The Chief Of Staff, GMAO ensures that strategic objectives are translated into actionable plans, fostering a culture of continuous improvement and accountability. Friedrich's leadership enhances the strategic execution of medical affairs and oncology programs, directly impacting Takeda Oncology's ability to serve patients worldwide.